Joincare Pharmaceutical Group Industry Co Ltd (600380.SS) stock: key figures, P/E, revenue and dividend

Health Care · Pharmaceuticals · China · ISIN CNE000001816

Price
9.12 CNY
Market cap
16.68 bn CNY
P/E (2025)
12.49
P/S (2025)
1.10
Dividend yield
2.41 %
Net margin
8.78 %
Return on equity (ROE)
5.48 %
Return on assets (ROA)
3.77 %

Joincare Pharmaceutical Group Industry Co Ltd financials

Fiscal year20242025
Revenue15.62 bn CNY15.22 bn CNY
Gross profit9.52 bn CNY9.50 bn CNY
Operating income3.62 bn CNY3.19 bn CNY
EBIT3.09 bn CNY3.45 bn CNY
Net income1.39 bn CNY1.34 bn CNY
Diluted EPS – continuing operations0.74 CNY0.73 CNY

Full history since 1997, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About Joincare Pharmaceutical Group Industry Co Ltd

Joincare Pharmaceutical Group Industry Co.,Ltd. engages in the research, development, production, and sale of pharmaceuticals and health care products in China and internationally. The company offers chemical pharmaceuticals for respiratory, gastroenterology, assisted reproduction, psychiatry, and anti-infection; chemical APIs and intermediates for drugs for humans and veterinary drugs; and traditional Chinese medicine, including cold medicine anti-viral granules and anti-tumor medicine. It also provides diagnostic reagents and equipment, such as mycoplasma pneumoniae IgM antibody test and antinuclear antibody test kit; OTC products which includes Taitai and Jingxin oral liquid, Eagle's American ginseng tea, and YikeTie; and biologics comprising tocilizumab and mouse nerve growth factor injection. The company was founded in 1992 and is headquartered in Shenzhen, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 23.10.2026. Details in the risk notice.